Type III D mucopolysaccharidosis (Sanfilippo D): Clinical course and symptoms

被引:0
|
作者
Tylki-Szymanska, A
Czartoryska, B
Gorska, D
Piesiewicz-Grzonkowska, E
机构
[1] Childrens Mem Hlth Inst, Dept Metab Dis, PL-04736 Warsaw, Poland
[2] Inst Psychiat & Neurol, Dept Genet, Warsaw, Poland
[3] SZNOZ, Dept Child Neuropsychiat, Warsaw, Poland
来源
ACTA PAEDIATRICA JAPONICA | 1998年 / 40卷 / 05期
关键词
N-acetylglucosamine-6-sulfatase; mucopolysaccharidosis type III D; Sanfilippo D;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A case of a rare form of Sanfilippo disease, mucopolysaccharidosis type III D is presented. The cause of the disease is a deficit of N-acetylglycosamine-6-sulfate sulfatase. Differences in clinical course and symptoms with type A and B Sanfilippo disease are shown (later presentation of symptoms, milder course, lack of distinct psychomotor regression and differences in characteristic phenotypic traits, such as facial features, joint contracture, tall height). It is suggested that type III D mucopolysaccharidosis be taken into account in the differentiation of mental retardation syndromes with hyperactivity.
引用
收藏
页码:492 / 494
页数:3
相关论文
共 50 条
  • [41] SEVERE MITRAL-INSUFFICIENCY IN MUCOPOLYSACCHARIDOSIS TYPE-III-B (SANFILIPPO SYNDROME)
    MUENZER, J
    BEEKMAN, RH
    PROFERA, LM
    BOVE, EL
    PEDIATRIC CARDIOLOGY, 1993, 14 (02) : 130 - 132
  • [43] Gene expression-targeted isoflavone therapy (GET IT) for mucopolysaccharidosis type III (Sanfilippo disease): A pilot clinical trial
    Wegrzyn, G.
    Jakobkiewicz-Banecka, J.
    Piotrowska, E.
    Malinowska, M.
    Maryniak, A.
    Tylki-Szymanska, A.
    Liberek, A.
    Czartoryska, B.
    Kloska, A.
    Wegrzyn, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 116 - 116
  • [44] Increased pituitary volumes in patients with Sanfilippo syndrome (mucopolysaccharidosis type 3, MPS III)
    Shiwei Huang
    Zachary J. Beatty
    Alexander M. Mckinney
    David R. Nascene
    Neuroradiology, 2023, 65 : 1381 - 1386
  • [45] Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III
    Tchan, Michel C.
    Sillence, David
    JOURNAL OF INTELLECTUAL & DEVELOPMENTAL DISABILITY, 2009, 34 (03): : 275 - 279
  • [46] Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period
    Malm, G.
    Mansson, J-E
    ACTA PAEDIATRICA, 2010, 99 (08) : 1253 - 1257
  • [47] MUCOPOLYSACCHARIDOSIS-III-A (SANFILIPPO DISEASE TYPE-A) - HISTOCHEMICAL, ELECTRON MICROSCOPICAL AND BIOCHEMICAL FINDINGS
    CAIN, H
    EGNER, E
    KRESSE, H
    BEITRAGE ZUR PATHOLOGIE, 1977, 160 (01): : 58 - 72
  • [48] A novel mutation in the NAGLU gene associated with Sanfilippo syndrome type B (mucopolysaccharidosis III B)
    Hettiarachchi, Dineshani
    Nethikumara, Nilaksha
    Pathirana, Bamunu Arachchi Pathiranage Sajeewani
    Weththasigha, Kalum
    Dissanayake, Weerabaddana Dilshani Niluka
    Dissanayake, Vajira H. W.
    CLINICAL CASE REPORTS, 2018, 6 (06): : 1051 - 1054
  • [49] Chronic subdural hematoma associated with mucopolysaccharidosis type III B (Sanfilippo's syndrome B)
    Kawasaki, Toshinari
    Kitagawa, Masashi
    Suzuki, Keita
    Wataya, Takafumi
    CHILDS NERVOUS SYSTEM, 2016, 32 (05) : 769 - 770
  • [50] The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape
    Bodamer, Olaf A.
    Giugliani, Roberto
    Wood, Tim
    MOLECULAR GENETICS AND METABOLISM, 2014, 113 (1-2) : 34 - 41